• Profile
Close

Lack of effect of Grastek on birch pollen-induced allergic rhinoconjunctivitis in the Environmental Exposure Unit

Annals of Allergy, Asthma, and Immunology Feb 23, 2018

Ellis AK, et al. - Grastek is a standardized sublingual immunotherapy tablet(SLIT-T) approved for the treatment of grass pollen-induced allergic rhinitis(AR) and conjunctivitis. Herein, the treatment impact of Grastek for birch pollen-induced AR was assessed in participants sensitized to both grass and birch pollen using the Environmental Exposure Unit(EEU). Findings demonstrated no by-stander effect of grass SLIT-T on birch pollen-induced AR symptoms. It was also observed that grass SLIT-T-induced symptomatic benefits were likely allergen specific.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay